Racial Disparities in Renal Outcomes Over Time Among Hospitalized Children With Systemic Lupus Erythematosus.
Racial Disparities in Renal Outcomes Over Time Among Hospitalized Children With Systemic Lupus Erythematosus.
复制标题
DOI:
10.1002/art.42127
复制
发表时间:
2022-08
影响因子:
13.3
通讯作者:
Son, Mary Beth F.
中科院分区:
文献类型:
--
作者:
Chang, Joyce C.;Sears, Cora;Torres, Veronica;Son, Mary Beth F.
Racial and ethnic minority groups have excess morbidity related to renal disease in pediatric-onset systemic lupus erythematosus (SLE). We evaluated temporal trends in renal outcomes and racial disparities among hospitalized children with SLE over 14 years. We identified patients ≤21 years-old with discharge diagnoses of SLE in the Pediatric Health Information System® inpatient database (2006-2019). Adverse renal outcomes included end-stage renal disease (ESRD), dialysis, or transplant, analyzed as a composite and separately. We estimated the odds of adverse renal outcomes at any hospitalization, or the first occurrence of an adverse renal outcome, adjusted for calendar period, patient characteristics, and clustering by hospital. We tested whether racial disparities differed by calendar period. There were 20,893 admissions for 7,434 SLE patients, of which 32%, 16%, 12% and 8% were Black, Hispanic White, Hispanic Other and Asian, respectively. Proportions of admissions with adverse renal outcomes decreased over time (p<0.01). Black children remained at highest risk of adverse renal outcomes at any admission (OR 2.5, 95% CI [1.8-3.5] vs. non-Hispanic White). Black and Asian children remained at higher risk of incident adverse renal outcomes, driven by ESRD among Black children (OR 1.6 [1.2-2.1]) and dialysis among Asians (OR 1.7 [1.1-2.7]). Relative disparities did not change significantly over time. Significant reductions in ESRD and dialysis occurred over time for children with SLE across all racial and ethnic groups. The lack of corresponding reductions in racial disparities highlights the need for targeted interventions to achieve greater treatment benefit among higher risk groups.
登录
查看更多内容
DOI:
10.1007/s40272-021-00455-1
发表时间:
2021-07
期刊:
Paediatric drugs
影响因子:
--
作者:
Barry E;Walsh JA;Weinrich SL;Beaupre D;Blasi E;Arenson DR;Jacobs IA
通讯作者:
Jacobs IA
影响因子:
4.7
作者:
Mina, Rina;von Scheven, Emily;Brunner, Hermine I.
通讯作者:
Brunner, Hermine I.
影响因子:
26.1
作者:
Khan, Sahar Q.;de Gonzalez, Amy Berrington;Shiels, Meredith S.
通讯作者:
Shiels, Meredith S.
影响因子:
4.7
作者:
Lim, Lily Siok Hoon;Pullenayegum, Eleanor;Silverman, Earl D.
通讯作者:
Silverman, Earl D.
DOI:
10.1016/j.pedn.2020.08.007
发表时间:
2020-11-01
影响因子:
2.4
作者:
Lipman, Terri H.;Willi, Steven M.;Hawkes, Colin P.
通讯作者:
Hawkes, Colin P.